178 related articles for article (PubMed ID: 28010059)
1. Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases.
Macdonald J; Henri J; Goodman L; Xiang D; Duan W; Shigdar S
ACS Chem Neurosci; 2017 Apr; 8(4):777-784. PubMed ID: 28010059
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells.
Macdonald J; Denoyer D; Henri J; Jamieson A; Burvenich IJG; Pouliot N; Shigdar S
Nucleic Acid Ther; 2020 Apr; 30(2):117-128. PubMed ID: 32027209
[TBL] [Abstract][Full Text] [Related]
3. Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity.
Macdonald J; Houghton P; Xiang D; Duan W; Shigdar S
Nucleic Acid Ther; 2016 Dec; 26(6):348-354. PubMed ID: 27500826
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in Vivo Blood-Brain Barrier Penetration by Circular Tau-Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy.
Li X; Yang Y; Zhao H; Zhu T; Yang Z; Xu H; Fu Y; Lin F; Pan X; Li L; Cui C; Hong M; Yang L; Wang KK; Tan W
J Am Chem Soc; 2020 Feb; 142(8):3862-3872. PubMed ID: 31991082
[TBL] [Abstract][Full Text] [Related]
5. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.
Shigdar S; Lin J; Yu Y; Pastuovic M; Wei M; Duan W
Cancer Sci; 2011 May; 102(5):991-8. PubMed ID: 21281402
[TBL] [Abstract][Full Text] [Related]
6. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
7. Selection and targeting of EpCAM protein by ssDNA aptamer.
Alshaer W; Ababneh N; Hatmal M; Izmirli H; Choukeife M; Shraim A; Sharar N; Abu-Shiekah A; Odeh F; Al Bawab A; Awidi A; Ismail S
PLoS One; 2017; 12(12):e0189558. PubMed ID: 29245156
[TBL] [Abstract][Full Text] [Related]
8. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
[TBL] [Abstract][Full Text] [Related]
9. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.
Mi Z; Guo H; Russell MB; Liu Y; Sullenger BA; Kuo PC
Mol Ther; 2009 Jan; 17(1):153-61. PubMed ID: 18985031
[TBL] [Abstract][Full Text] [Related]
10. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
[TBL] [Abstract][Full Text] [Related]
11. A DNA Aptameric Ligand of Human Transferrin Receptor Generated by Cell-SELEX.
Zhang N; Bing T; Shen L; Feng L; Liu X; Shangguan D
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445629
[TBL] [Abstract][Full Text] [Related]
12. In silico designed RNA aptamer against epithelial cell adhesion molecule for cancer cell imaging.
Bavi R; Liu Z; Han Z; Zhang H; Gu Y
Biochem Biophys Res Commun; 2019 Feb; 509(4):937-942. PubMed ID: 30648555
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Use of a Multi-DNA Aptamer-Based Payload/Targeting System To Study Dopamine Dysregulation in the Central Nervous System.
McConnell EM; Ventura K; Dwyer Z; Hunt V; Koudrina A; Holahan MR; DeRosa MC
ACS Chem Neurosci; 2019 Jan; 10(1):371-383. PubMed ID: 30160936
[TBL] [Abstract][Full Text] [Related]
14. Optical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell.
Hwang JY; Kim ST; Han HS; Kim K; Han JS
Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27886058
[TBL] [Abstract][Full Text] [Related]
15. EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging.
Li F; Zeng Z; Hamilton D; Zu Y; Li Z
Bioconjug Chem; 2021 Jun; 32(6):1139-1145. PubMed ID: 34014641
[TBL] [Abstract][Full Text] [Related]
16. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effects of aptamer-doxorubicin conjugates in an ovarian cancer cell line.
Henri JL; Nakhjavani M; McCoombe S; Shigdar S
Biochimie; 2023 Jan; 204():108-117. PubMed ID: 36155804
[TBL] [Abstract][Full Text] [Related]
18. A Flow Cytometry-based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer.
Nakhjavani M; Giles B; Strom M; Vi C; Attenborough S; Shigdar S
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190297
[TBL] [Abstract][Full Text] [Related]
19. Single molecular recognition force spectroscopy study of a DNA aptamer with the target epithelial cell adhesion molecule.
Wang N; Liu H; Hao J; Bai X; Li H; Zhang Z; Wang H; Tang J
Analyst; 2015 Sep; 140(18):6226-9. PubMed ID: 26229987
[TBL] [Abstract][Full Text] [Related]
20. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
